Adipose-Derived Stem Cells (ADSCs) Injections for Liver Cirrhosis

Trial Profile

Adipose-Derived Stem Cells (ADSCs) Injections for Liver Cirrhosis

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 10 Jul 2017

At a glance

  • Drugs GXHPC 1 (Primary)
  • Indications Liver cirrhosis
  • Focus Therapeutic Use
  • Sponsors GWOXI Stem Cell Applied Technology
  • Most Recent Events

    • 04 Jul 2017 Planned End Date changed from 1 Sep 2017 to 31 Jan 2018.
    • 04 Jul 2017 Planned primary completion date changed from 1 Jul 2017 to 4 Jul 2017.
    • 04 Jul 2017 Status changed from recruiting to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top